Key result
Symptomatic Brugada syndrome is linked to ~19% lower nocturnal SDANN versus asymptomatic cases.
Why the study?
Risk-stratification of asymptomatic Brugada Syndrome patients remains a key issue, and additional risk markers are needed beyond known ECG patterns and inducibility.
Observational (n=47)
Absolute Event Rate: 46% vs 57%
p-value: p=0.02
Symptomatic BS patients showed lower nighttime HRV than asymptomatic ones; leaves open whether autonomic indices enhance risk stratification beyond spontaneous type 1 pattern.
AIMS: Risk-stratification of asymptomatic Brugada Syndrome (BS) patients remains a key-issue. A typical spontaneous BS-ECG pattern and ventricular tachycardia (VT)/ventricular fibrillation (VF) inducibility are two recognized risk markers. The aim of the study was to identify additional risk markers in asymptomatic BS. METHODS AND RESULTS: We have compared Holter recordings in symptomatic and in asymptomatic patients with BS. Heart rate variability (HRV), QT-interval rate-dependence and ST-segment elevation (ST-SE) were analysed. The study population included 47 BS patients (M=36, mean age=45+/-13 years) with a malignant ventricular arrhythmia in 11 cases, an unexplained syncope in 10 cases and no symptoms in the remaining 26 cases. A typical spontaneous BS-ECG was present in 21 cases and a drug-induced BS-ECG in 26 cases. A downward trend of the time domain variables of HRV was observed. During the nocturnal period, standard deviation (SD) of the 5min averaged NN intervals (SDANN) (46+/-13 vs 57+/-18ms, P=0.02) and ultra low frequency component (3287+/-2312 vs 5030+/-3270 ms(2), P=0.04) were significantly lower in symptomatic versus asymptomatic patients. In contrast, no difference was found in QT-interval rate dependence and in ST-SE. At multivariate logistic regression, VT/VF inducibility, typical spontaneous BS-ECG and a decreased nocturnal SDANN were associated with arrhythmic events (P=0.003). CONCLUSIONS: A decreased nocturnal SDANN was an independent marker of arrhythmic events in these BS patients.
No takes yet. Share an insight, caveat, or question.
Jean‐Sylvain Hermida (2003) conducted an observational in Brugada Syndrome (n=47). Symptomatic Brugada Syndrome vs. Asymptomatic Brugada Syndrome was evaluated on Nocturnal standard deviation of the 5min averaged NN intervals (SDANN) (p=0.02). Symptomatic Brugada Syndrome patients had significantly lower nocturnal SDANN compared to asymptomatic patients (46 vs 57 ms, P=0.02), serving as an independent marker of arrhythmic events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: